$19.5 million NIH contract targets developing medications for drug-resistant epilepsy
(SALT LAKE CITY)--The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the...